Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine

Virology Journal

Volumn 7, Issue , 2010, Pages

  El Ottol, Abed El Kader Y ^a   Elmanama, Abdelraouf A ^b   Ayesh, Basim M ^c  

^a AlShifa Hospital   (Palestine)

^b ISLAMIC UNIVERSITY OF GAZA   (Palestine)

^c AL AQSA UNIVERSITY   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA; HEPATITIS C ANTIBODY;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CHILD; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PALESTINE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; VIRUS TRANSMISSION; ADOLESCENT; BLOOD; HEPATITIS B; HEPATITIS C; ISOLATION AND PURIFICATION; LIVER FUNCTION TEST; MIDDLE AGED; MIDDLE EAST; PREVALENCE; RENAL REPLACEMENT THERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHILD; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MIDDLE EAST; PREVALENCE; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; YOUNG ADULT;

EID: 79952047413     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-210     Document Type: Article

References (39)

1. Hepatitis and HIV infection during haemodialysis. D Saha SK Agarwal, J Indian Med Assoc 2001 99 4 194 199 203,213 11666025
2. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca. K Boulaajaj Y Elomari B Elmaliki B Madkouri D Zaid N Benchemsi, Nephrol Ther 2005 1 5 274 284 16895696
3. Hepatitis B infection among patients receiving chronic hemodialysis at the royal medical services in Jordan. M Al Hijazat Y Ajlouni, Saudi J Kidney Dis Transpl 2008 19 2 260 267 18310881
4. Prevalence of hepatitis B and C markers in patients on maintenance hemodialysis in Najran. LA Khan SA Khan, Saudi Med J 2001 22 7 641 642 11479651
5. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia. WY Almawi AA Qadi H Tamim G Ameen A Bu-Ali S Arrayid MM Abou Jaoude, Transplant Proc 2004 36 6 1824 1826 10.1016/j.transproceed.2004.07.019 15350487
6. Hepatitis C virus in hemodialysis patients and blood donors in Lebanon. RE Naman I Mansour S Klayme G Khalil, J Med Liban 1996 44 1 4 9 8965318
7. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. S Bdour, J Med Microbiol 2002 51 8 700 704 12171303
8. Viral hepatitis C in chronic hemodialysis patients in southern Tunisia, prevalence and risk factor. J Hachicha A Hammami H Masmoudi M Ben Hmida H Karray M Kharrat F Kammoun A Jarraya, Ann Med Interne 1995 146 5 295 298
9. Hepatitis C virus genotype and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. AS Abdulkarim NN Zein JJ Germer CP Kolbert L Kabbani KL Krajnik A Hola MN Agha M Tourogman DH Persing, Am J Trop Med Hyg 1998 59 4 571 576 9790432
10. Host defenses and immunologic alterations associated with chronic hemodialysis. SE Goldbloom WP Reed, Ann Intern Med 1980 93 4 597 613 7001976
11. Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. F Fabrizi P Martin V Dixit M Brezina J Russell A Conrad P Schmid S Gerosa G Gitnick, Am J Nephrol 1999 19 3 383 388 10.1159/000013482 10393375
12. Palestinian clinical laboratory tests guide. Ministry Of Health, MOH 2005
13. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. L Stuyver R Rossau A Wyseur M Duhamel B Vanderborght H Van Heuverswyn G Maertens, J Gen Virol 1993 74 pt 6 1093 1102 10.1099/0022-1317-74-6-1093 8389799
14. Chronic hepatitis virus infections in patients on renal replacement therapy. T Feher PM Ambuhi, Nephrol Dial Transplant 2004 19 5 1049 1053 10.1093/ndt/gfh080 15004267
15. Hepatits virus infection in haemodialysis patients from Moldavia. A Covic L Iancu C Apetrei D Scripcaru C Volovat I Mititiuc M Covic, Nephrol Dial Transplant 1999 14 1 40 45 10.1093/ndt/14.1.40 10052474
16. Hepatitis C and Hepatitis B Virus Infection in Different Hemodialysis Units in Belo Horizonte, Minas Gerais, Brazil. SU Busek EH Bab HA Tavares Filho L Pimenta A Salomo R Corra-Oliveira GC Oliveira, Mem Inst Oswaldo Cruz 2002 97 6 775 778 10.1590/S0074-02762002000600003 12386694
17. Acute hepatitis C virus infection after a travel in India. S Jauréguiberry L Grandière-Pérez S Ansart H Laklache S Métivier E Caumes, J Travel Med 2005 12 1 55 56 15996468
18. Molecular epidemiology of the hepatitis C virus in Brazil. S Busek G Oliveira, Genet Mol Res 2003 2 1 117 123 12917808
19. Prevalence and risk factors of HBsAg in Gaza: Implications for prevention and control. K Yassin R Awad AJ Tebi A Queder U Laaser, J Infect 2002 44 4 252 256 10.1053/jinf.2001.0998 12099733
20. Epidemiology of acute hepatitis B infection in Lebnon. W Kalaajieh M Deeaoui A Chbani-Rima, Med Mal Infect 2002 32 7 382 386 10.1016/S0399-077X(02) 00385-2 (Pubitemid 34760500)
21. Hepatitis C virus infection in hemodialysis patients from Tunisia: national survey by serologic and molecular methods. K Ayed Y Gorgi T Ben Abdallah H Aouadi S Jendoubi-Ayed I Sfar H Makni, Transplant Proc 2003 35 7 2573 2575 10.1016/j.transproceed.2003.09.005 14612022
22. Hepatitis C prevalence and risk factors in hemodialysis patients in central Brazil: a survey by polymerase chain reaction and serological methods. MA Carneiro RM Martins SA Teles SA Silva CL Lopes DD Cardoso BO Vanderborght CF Yoshida, Mem Inst Oswaldo Cruz 2001 96 6 765 769 10.1590/S0074-02762001000600003 11562698
23. HCV RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece. EI Rigopoulou I Stefanidis C Liaskos EK Zervou C Rizos P Mina K Zachou C Syrganis E Patsidis G Kyriakopoulos L Sdrakas N Tsianas GN Dalekos, J Clin Virol 2005 34 1 81 85 10.1016/j.jcv.2005.05.007 16009596
24. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. N Furusyo J Hayashi I Ariyama Y Sawayama Y Etoh M Shigematsu S Kashiwagi, Am J Gastroenterol 2000 95 2 490 496 10.1111/j.1572-0241.2000.01773.x 10685756
25. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a signiticant number of patients with HCV infection. J Bukh P Wantzin K Krogsgaard F Knudsen RH Purcell RH Miller, J Infect Dis 1993 168 6 1343 1348 7504031
26. Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazi. AC Albuquerque MR Colho EP Lopes MF Lemos RC Moreira, Mem Inst Oswaldo Cruz-Rio de Janeiro 2005 100 5 467 470
27. Hepatitis C prevalence and risk factors in hemodialysis patients in central Brazil: a survey by polymerase chain reaction and serological methods. MA Carneiro RM Martins SA Teles SA Silva CL Lopes DD Cardoso BO Vanderborght CF Yoshida, Mem Inst Oswaldo Cruz 2001 96 6 765 769 10.1590/S0074-02762001000600003 11562698
28. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. H Hinrichsen G Leimenstoll G Stegen H Schrader UR Fölsch WE Schmidt Group PHV Study, Gut 2002 51 3 429 433 10.1136/gut.51.3.429 12171969
29. Prevelance of HBV and HCV dual infection in patients on hemodialysis. GA Reddy KV Dakshinamurthy P Neelaprasad T Gangadhar V Lakshmi, Indian J Med Microbiol 2005 23 1 41 43 10.4103/0255-0857.13872 15928421
30. Identification of hepatitis C seroconversion resulting from nosocomial transmission on a haemodiolysis unit: implications for infection control and laboratory screening. DN Irish C Blake J Christophers JE Craske L Burnapp IC Abbs EM MacMahon P Muir JE Banatvala P Simmonds, J Med Virol 1999 59 2 135 140 10.1002/(SICI)1096-9071(199910)59:2<135::AID-JMV23.0.CO;2-Y 10459146
31. Frequent patient to patient transmission of hepatitis C virus in a haematology ward. T Allander A Gruber M Naghavi A Beyene T Söderström M Björkholm L Grillner MA Persson, Lancet 1995 345 8950 603 607 10.1016/S0140-6736(95)90518-9 7898176
32. Transmission of hepatitis C virus between hemodialysis patients sharing the same machine. C Sartor P Brunet S Simon C Tamalet Y Berland M Drancourt, Infect Control Hosp Epidemiol 2004 25 7 609 611 10.1086/502448 15301036
33. Prevalence of hepatitis C and G virus infection in chronic hemidialysis patients. M de Medina M Ashby V Schlüter M Hill B Leclerq JP Pennell LJ Jeffers KR Reddy ER Schiff G Hess GO Perez, Am J Kidney Dis 1998 31 2 224 226 10.1053/ajkd.1998.v31.pm9469491 9469491
34. Determination of the cut off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viraemia. EP Lopes EC Gouveia AC Albuquerque LH Sette LA Mello RC Moreira MR Coelho, J clin Virol 2006 35 3 298 302 10.1016/j.jcv.2005.09.010 16290052
35. Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. M el-Sadawy H Ragab H el-Toukhy Ael-L el-Mor AM Mangoud MH Eissa AF Afefy E el-Shorbagy IA Ibrahem S Mahrous A Abdel-Monem EI Sabee A Ismail TA Morsy S Etewa E Nor Edin Y Mostafa Y Abouel-Magd MI Hassan K Lakouz K Abdel-Aziz G el-Hady M Saber, J Egypt Soc Parasitol 2004 34 1 Suppl 367 384 15124747
36. Hepatits C virus among chronic dialysis patients in the south of France: a collaborative study. B Dussol P Berthezène P Brunet C Roubicek Y Berland, Am J Kidney Dis 1995 25 3 399 404 10.1016/0272-6386(95)90100-0 7532916
37. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. F Fabrizi G Lunghi S Finazzi P Colucci A Pagano C Ponticelli F Locatelli, Am J Kidney Dis 2001 38 5 1009 1015 10.1053/ajkd.2001.28590 11684554
38. Identification of the cut-off value for serum alanine aminotransferase in hepatitis C screening of patients with chronic renal failure on hemodialysis. EC Gouveia EP Lopes I Moura M Cruz L Kosminsky JR Pernambuco, Rev Soc Braz Med Trop 2004 37 1 18 21
39. Hepatitis C infection and the patients with end-stage renal disease. F Fabrizi F Poordad P Martin, Hepat 2002 36 1 3 10 10.1053/jhep.2002.34613 (Pubitemid 34700756)